Stem cell harvesting improved

A study published in the current issue of the journal, Blood, demonstrates that cancer patients who received AMD3100
(MOZOBIL(TM)) plus granulocyte-colony stimulating factor (G-CSF) were able to collect more stem cells in less time
 compared to the standard mobilization regimen, G-CSF alone.